Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

Healthcare Industrials Auto Parts Diversified Industrials
HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the... see more

Recent & Breaking News (TSX:HLS)

HLS Therapeutics to Host 2018 Fourth Quarter and Year-End Financial Results Conference Call

Canada NewsWire March 7, 2019

HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Canada NewsWire February 19, 2019

HLS Therapeutics Announces Graduation to the Toronto Stock Exchange

Canada NewsWire February 6, 2019

HLS Therapeutics Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Canada NewsWire January 29, 2019

HLS Therapeutics Announces Q3 2018 Financial Results

Canada NewsWire November 15, 2018

HLS Therapeutics Announces that Amarin's Vascepa ® (icosapent ethyl) Demonstrates 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attack and Stroke in REDUCE-IT™, which Supports 25% Overall Reduction in Five-Point Major Ad

Canada NewsWire November 12, 2018

HLS Therapeutics to Host 2018 Third Quarter Results Conference Call

Canada NewsWire November 1, 2018

HLS Therapeutics Announces that Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules Met Primary Endpoint

Canada NewsWire September 24, 2018

Silicon Valley Bank Serves as Joint Lead Arranger for $125 Million Financing for HLS Therapeutics

PR Newswire September 12, 2018

HLS Therapeutics Appoints Tim Hendrickson as CFO

Canada NewsWire September 6, 2018

HLS Therapeutics Announces Grant of Stock Options

Canada NewsWire August 22, 2018

HLS Therapeutics Announces Q2 2018 Financial Results

Canada NewsWire August 15, 2018

HLS Therapeutics to Host 2018 Second Quarter Results Conference Call

Canada NewsWire July 30, 2018

HLS Therapeutics Reports Annual Meeting Results

Canada NewsWire June 25, 2018

HLS Therapeutics to Host Annual Shareholder Meeting

Canada NewsWire June 15, 2018

HLS Therapeutics Enters into Automatic Share Purchase Plan

Canada NewsWire May 30, 2018

HLS Therapeutics Announces Q1 2018 Financial Results

Canada NewsWire May 16, 2018

HLS Therapeutics Announces Normal Course Issuer Bid

Canada NewsWire May 9, 2018

HLS Therapeutics to Host 2018 First Quarter Results Conference Call

Canada NewsWire May 9, 2018

HLS Appoints Ryan Lennox as General Counsel

Canada NewsWire May 7, 2018